Companies should have a solid plan for what to do with a generic domain if they are lucky enough to obtain it.

Democrats recently moved into a narrow lead, though handicappers still give Republicans a good chance to hold the House.

In response to rapidly declining profits and the downfall of ADHD drug Vyvanse, Takeda is planning to throw 140 billion ...

Big Pharma giant Pfizer confirmed on Wednesday that it will settle more than 10,000 lawsuits over allegations that the ...

Personalised nutrition apps have become flavour of the day among certain consumers seeking guidance on an individual basis.

Let’s just skip to the chase, because two things are true: The Onn 4K Pro Streaming Device has a horribly generic name. And I ...

Delivered Q1’24 Record Belbuca® Revenue of $50.7 Million; Total Prescriptions Up 4.2% Year-over-Year – – Achieved Q1’24 GAAP ...

May 8, 2024 Vanda Pharmaceuticals Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third ...

In the earnings report, CEO Christophe Weber said Takeda is navigating short-term generic competition, but he expects the ...

Teva Pharmaceutical Industries Limited TEVA reported first-quarter 2024 adjusted earnings of 48 cents per share, which missed the Zacks Consensus Estimate of 51 cents per share. Earnings rose 20% year ...

The Czech Health Ministry has introduced amendments to the public insurance law to enhance healthcare accessibility and ...

Moving to Keveyis, the Keveyis brand remains incredibly resilient in the face of generic competition ... which included net proceeds from the Haven term loan refinancing of approximately $35 million.